Cargando…

Patient experience of whole body diffusion weighted magnetic resonance imaging (WB-MRI) for staging myeloma

Detalles Bibliográficos
Autores principales:	Otero, S, Kaiser, M, Pawlyn, C, Giles, S, Scurr, E, Messiou, C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4601110/ http://dx.doi.org/10.1186/1470-7330-15-S1-P13

Ejemplares similares

Whole body diffusion weighted MRI – a new view of myeloma
por: Messiou, Christina, et al.
Publicado: (2015)

Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma?
por: Pawlyn, C, et al.
Publicado: (2016)

Detection of avascular necrosis on routine diffusion-weighted whole body MRI in patients with multiple myeloma
por: Ahmed, Naeem, et al.
Publicado: (2019)

Development of machine learning support for reading whole body diffusion-weighted MRI (WB-MRI) in myeloma for the detection and quantification of the extent of disease before and after treatment (MALIMAR): protocol for a cross-sectional diagnostic test accuracy study
por: Satchwell, Laura, et al.
Publicado: (2022)

Repeatability and test–retest reproducibility of mean apparent diffusion coefficient measurements of focal and diffuse disease in relapsed multiple myeloma at 3T whole body diffusion-weighted MRI (WB-DW-MRI)
por: ElGendy, Khalil, et al.
Publicado: (2022)

Accuracy of whole-body diffusion-weighted MRI (WB-DWI/MRI) in diagnosis, staging and follow-up of gastric cancer, in comparison to CT: a pilot study
por: De Vuysere, Sofie, et al.
Publicado: (2021)

Whole-body magnetic resonance imaging (WB-MRI) for cancer screening: recommendations for use
por: Petralia, Giuseppe, et al.
Publicado: (2021)

Inter-observer agreement of baseline whole body MRI in multiple myeloma
por: Croft, James, et al.
Publicado: (2020)

The Role of Whole-Body Magnetic Resonance Imaging (WB-MRI) in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
por: Alashkar, Ferras, et al.
Publicado: (2018)

Repeatability and reproducibility of apparent diffusion coefficient and fat fraction measurement of focal myeloma lesions on whole body magnetic resonance imaging
por: Barwick, Tara, et al.
Publicado: (2021)

Apparent diffusion coefficient of vertebral haemangiomas allows differentiation from malignant focal deposits in whole-body diffusion-weighted MRI
por: Winfield, Jessica M., et al.
Publicado: (2017)

Predictors of patient preference for either whole body magnetic resonance imaging (WB‐MRI) or CT/ PET‐CT for staging colorectal or lung cancer
por: Miles, Anne, et al.
Publicado: (2020)

Whole-body magnetic resonance imaging (WB-MRI) for cancer screening in asymptomatic subjects of the general population: review and recommendations
por: Zugni, Fabio, et al.
Publicado: (2020)

Accelerating Whole-Body Diffusion-weighted MRI with Deep Learning–based Denoising Image Filters
por: Zormpas-Petridis, Konstantinos, et al.
Publicado: (2021)

Assessing myeloma bone disease with whole-body diffusion-weighted imaging: comparison with x-ray skeletal survey by region and relationship with laboratory estimates of disease burden
por: Giles, S.L., et al.
Publicado: (2015)

Interobserver agreement of whole-body magnetic resonance imaging is superior to whole-body computed tomography for assessing disease burden in patients with multiple myeloma
por: Lai, Alta Y. T., et al.
Publicado: (2019)

Improving real‐world myeloma patient access to whole body MRI through “open‐access” knowledge sharing: The UK experience
por: Kaiser, Martin F, et al.
Publicado: (2020)

Implementation of Whole-Body MRI (MY-RADS) within the OPTIMUM/MUKnine multi-centre clinical trial for patients with myeloma
por: Rata, Mihaela, et al.
Publicado: (2022)

Optimisation of b-values for the accurate estimation of the apparent diffusion coefficient (ADC) in whole-body diffusion-weighted MRI in patients with metastatic melanoma
por: Knill, Annemarie K., et al.
Publicado: (2022)

Whole-body diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient values as prognostic factors in multiple myeloma
por: Costachescu, Dan, et al.
Publicado: (2021)

The Apparent Diffusion Coefficient of Diffusion-Weighted Whole-Body Magnetic Resonance Imaging Affects the Survival of Multiple Myeloma Independently
por: Zhang, Bei, et al.
Publicado: (2022)

Evaluation of whole-body MRI with diffusion-weighted sequences in the staging of pediatric cancer patients
por: de Oliveira, Alex Dias, et al.
Publicado: (2020)

Comparison of standard staging protocol and WB-MRI for initial staging of rectal cancer
por: Yoon, JH, et al.
Publicado: (2015)

Assessment of early treatment response on MRI in multiple myeloma: Comparative study of whole-body diffusion-weighted and lumbar spinal MRI
por: Takasu, Miyuki, et al.
Publicado: (2020)

Role of whole-body diffusion-weighted imaging in evaluation of multiple myeloma
por: Wang, Jiping, et al.
Publicado: (2021)

Optimising TNM Staging of Patients with Prostate Cancer Using WB-MRI
por: Pasoglou, Vassiliki, et al.
Publicado: (2016)

Correlations between apparent diffusion coefficient values of WB-DWI and clinical parameters in multiple myeloma
por: Zhang, Bei, et al.
Publicado: (2021)

Whole-body MRI including diffusion-weighted imaging compared to CT for staging of malignant melanoma
por: Mosavi, Firas, et al.
Publicado: (2013)

Image quality in whole-body MRI using the MY-RADS protocol in a prospective multi-centre multiple myeloma study
por: Keaveney, Sam, et al.
Publicado: (2023)

Comparison of (68)Ga-Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography Computed Tomography (PET-CT) and Whole-Body Magnetic Resonance Imaging (WB-MRI) with Diffusion Sequences (DWI) in the Staging of Advanced Prostate Cancer
por: Van Damme, Julien, et al.
Publicado: (2021)

Noise-Corrected, Exponentially Weighted, Diffusion-Weighted MRI (niceDWI) Improves Image Signal Uniformity in Whole-Body Imaging of Metastatic Prostate Cancer
por: Blackledge, Matthew D., et al.
Publicado: (2020)

Whole-body MRI and diffusion MRI
por: Padhani, Anwar R
Publicado: (2014)

Whole-body diffusion-weighted MRI for staging of women with cancer during pregnancy: a pilot study
por: Dresen, RC, et al.
Publicado: (2015)

Whole-body diffusion-weighted imaging for staging malignant lymphoma in children
por: Kwee, Thomas C., et al.
Publicado: (2010)

Imaging of treatment response and minimal residual disease in multiple myeloma: state of the art WB-MRI and PET/CT
por: Lecouvet, Frederic E., et al.
Publicado: (2021)

UK quantitative WB-DWI technical workgroup: consensus meeting recommendations on optimisation, quality control, processing and analysis of quantitative whole-body diffusion-weighted imaging for cancer
por: Barnes, Anna, et al.
Publicado: (2018)

Tumour characterisation, staging and operability assessment in ovarian carcinoma: whole body diffusion-weighted MRI versus CT
por: Michielsen, K, et al.
Publicado: (2015)

Whole body MRI with Diffusion Weighted Imaging versus 18F-fluorodeoxyglucose-PET/CT in the staging of lymphomas
por: Maccioni, Francesca, et al.
Publicado: (2023)

Whole-Body Functional MRI and PET/MRI in Multiple Myeloma
por: Mulé, Sébastien, et al.
Publicado: (2020)

Whole-body diffusion-weighted imaging in lymphoma
por: Lin, C., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_mjqci5tsnm6mg75guld61u894n